Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Benzene and substituted derivatives
(total 172 related compounds in database, current show from 151 to 160)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
N-[3-(2-aminopyrimidin-5-yl)phenyl]-3,5-dibromobenzamide Depiction based on curated SMILES N Br Br NH 2 O N H N Staphylococcus Biofilm Preclinical (in vitro) Weig AW, et al. 2021. RSC Med Chem
N-[4-(2-aminopyrimidin-4-yl)phenyl]-3,5-dichlorobenzamide Depiction based on curated SMILES O N Cl Cl NH 2 N H N Staphylococcus Biofilm Preclinical (in vitro) Weig AW, et al. 2021. RSC Med Chem
Ethyl 4-(3-(2-furyl)-4-(4-hydroxyphenyl)-6-oxo-4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)benzoate Depiction based on curated SMILES N OH O O CH 3 HN N O O Vibrio Stress survival Preclinical (in vitro) Stanbery L, et al. 2017. Drug Des Devel Ther
8-hydroxy-7-(p-tolylsulfonyl)-5-(p-tolylsulfonylamino)quinoline Depiction based on curated SMILES OH H 3 C O O S HN N CH 3 O O S Vibrio Stress survival Preclinical (in vitro) Stanbery L, et al. 2017. Drug Des Devel Ther
Imidocarb Depiction based on curated SMILES O NH N NH N H NH N Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
N-(1,3-dimethyl-2-oxo-6-pyrrolidin-1-yl-2,3-dihydro-1H-benzimidazol-5-yl)-N'-(3,4-dimethylphenyl)urea Depiction based on curated SMILES CH 3 CH 3 N O H 3 C N N CH 3 N H O N H Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Harmon DE, et al. 2010. Antimicrob Agents Chemother
1-{4-[(2-nitrophenyl)sulfonyl]piperazin-1-yl}-2-phenoxyethanone Depiction based on curated SMILES S _ O O + N O O O N N O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-5-chloro-N-(3,4-dichlorophenyl)benzamide Depiction based on curated SMILES Cl Cl N H O Cl N H O O S N S N Yersinia TTSS (Type III secretion system) Preclinical (in vitro) Kauppi AM, et al. 2003. Chem Biol
2-chloro-4-{5-[(E)-2-(4,6-dihydroxy-5-nitropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid Depiction based on curated SMILES O NH O _ O O + N HO N O Cl OH Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
2-chloro-5-[5-[(Z)-[1-(furan-2-ylmethyl)-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene]methyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O O N S N H O O Cl OH Yersinia TTSS secreted effectors Preclinical (in vitro) Eriksson J, et al. 2012. Adv Exp Med Biol
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  6  7  8  9  10  11  12  13  14  15  16  17  18 



Back to top
2004-2025 NIPB, CAMS&PUMC